A B S T R A C T The chemotactic migration of leukocytes is preceded by an alteration in the cells' shape from round to a characteristic polar configuration. We have developed an assay that shows that human monocytes, when exposed to chemoattractant in suspension, assume this polarized shape. The three types ofchemoattractants studied, a chemotactic lymphokine, complement-activated serum, and the N-formylated oligopeptides, all induced polarization in a time, temperature, and dose-dependent fashion. 
A B S T R A C T The chemotactic migration of leukocytes is preceded by an alteration in the cells' shape from round to a characteristic polar configuration. We have developed an assay that shows that human monocytes, when exposed to chemoattractant in suspension, assume this polarized shape. The three types ofchemoattractants studied, a chemotactic lymphokine, complement-activated serum, and the N-formylated oligopeptides, all induced polarization in a time, temperature, and dose-dependent fashion. Nonchemotactic agents such as mitogens or phorbol myristate acetate did not induce polarization. At 370C, polarization was rapid (<1 min) and was inhibitable by cytochalasin B, sodium azide, or low temperature. A series of N-formylated oligopeptides were studied and their activity in inducing polarization correlated closely (r > 0.99) with their chemotactic activity. Of the entire population of circulating monocytes there is a subpopulation of cells that is capable of polarizing in response to chemotactic stirnuli. The maximum percentage of monocytes which polarized to any chemotactic factor was -60%. Furthermore, the combination of several chemotactic factors could not increase the percentage of polarized monocytes above the maximum obtained with an optimal dose of any single chemoattractant. The data also demonstrate that high doses of a chemoattractant can induce a state of cross-desensitization in monocytes that blocks the response of the cells to other types of chemotactic factors. These results support the concept that the monocytes that do respond to chemotactic stimuli are capable of responding to any of several attractants.
INTRODUCTION
Chemotaxis, the directed migration of cells along a chemical gradient, appears to be an important mechanism by which phagocytic cells accumulate at sites of inflammation. The development of assays for measuring chemotaxis in vitro has facilitated the study of leukocyte physiology as well as the pathogenesis of diseases, both in humans and animals (1) . In particular, an assay for the chemotactic responsiveness of human blood monocytes (2) has enabled the study of defects in monocyte chemotactic response associated with neoplasia (3) (4) (5) (6) (7) (8) and other diseases (9) (10) (11) (12) (13) .
The leukocyte chemotaxis assays currently in general use measure either the number of cells that have migrated through a porous membrane, the distance that cells have migrated into a membrane or under agarose, or the locomotion of individual cells that are adhered to glass (2, (14) (15) (16) (17) (18) (19) . Whereas these assays often yield a great deal of information, they measure the end result of a complex series of events including the binding of chemotactic factors to the plasma membrane (20) (21) (22) (23) (24) , the induction oftransmembrane signals (25, 26) , the reorganization of cytoskeletal elements (27) , the assumption of an elongated, polarized configutation (19) , and finally, actual cell movement. The measurement of chemotaxis in vitro, particularly by mononuclear cells, requires a lengthy assay period ranging from 60-90 min using even the quickest procedures (2) Depletion or enrichment of peroxidase-positive cells in mononuclear cell suspensions. Mononuclear leukocytes (1.5 x 107 in 10 ml GBSS, 33% peroxidase positive) were incubated for 60 min at 37°C in plastic petri dishes (100 x 15 mm; Fisher Scientific Co., Pittsburgh, Pa.). The supernate was removed, centrifuged for 15 min at 400 g and 4°C, and the cells resuspended in GBSS. Approximately 40% of the total cells were recovered in the supernate; -11% of these cells were peroxidase positive. Percoll density gradients were also used to enrich and deplete the cell suspensions of peroxidase positive cells. Mononuclear cells were washed once in calcium and magnesium-free phosphate-buffered saline (0.7 mM P04; 0.2% glucose; 4.0 mM KCl) and resuspended to 7 x 106 cells! ml in 4% Percoll (vol/vol; Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) in calcium and magnesium-free phosphatebuffered saline. 3 ml of this suspension was then layered on top of a gradient consisting of 3 ml each of 5, 6, 7, and 8% Percoll (all vol/vol in calcium and magnesium-free phosphatebuffered saline). The cell suspension was then centrifuged for 40 min at 400 g and 4°C. The cells located at the interfaces between the 6 and 7% Percoll (fraction II) and the 7 and 8% Percoll (fraction III) were removed, washed twice with a large excess of GBSS, and resuspended in GBSS. Approximately 23% of the total cells were recovered in fraction II with -74% ' Abbreviations used in this paper: AHS, zymosan-activated human serum; Con A, concanavalin A; EC5o, concentration resulting in half-maximal response; GBSS, Gey's balanced salt solution; FMLP, N-formyl-methionyl-leucyl-phenylalanine; FMMM, N-formyl-methionyl-methionyl-methionine; FMP, N-formyl-methionyl-phenylalanine; FNILP, Nformyl-norleucyl-leucyl-phenylalanine; LDCF, lymphocyte-derived chemotactic factor; PHA, phytohemagglutin P. Chemotactic peptides and other reagents. N-formylmethionyl-leucyl-phenylalanine (FMLP), N-formyl-methionyl-phenylalanine (FMP), phorbol 12-myristate 13-acetate, and cytochalasin B were all obtained from Sigma Chemical Co., St. Louis, Mo. N-formyl-norleucyl-leucyl-phenylalanine (FNlLP) was obtained from Peninsula Laboratories, Inc., San Carlos, Calif. N-formyl-methionyl-methionyl-methionine (FMMM) and methionyl-methionyl-methionine were obtained from Andrulis Research Corp., Bethesda, Md. Concanavalin A (Con A, crystallized three times) was obtained from Miles Laboratories Inc., Elkhart, Ind. Phytohemagglutin P (PHA) was obtained from Burroughs-Wellcome Co., Greenville, N. C. Sodiuim azide was obtained from Fisher Scientific Co.
Zymnosan-actiuated human serum (AHS) and lymphocytederived chemotactic factor (LDCF). AHS was prepared as previously described (32) . Briefly, serum was incubated with zymosan (10 mg/ml; Sigma Chemical Co.) for 60 min at 37°C.
The particulate zymosan vas removed by centrifugation and the serum heated for 30 min at 56°C. LDCF was prepared as described (33) . Brieflv, human mononuclear cells obtained sterilely from venous blood on Ficoll-Hypaque density gradients (30) were washed twice in RPMI 1640 medium (pH 7.0; Gibco Laboratories, Grand Island Biological Co., Grand Island, N. Y.) and adjusted to 2.0 x 106 cells/ml. The cells were incubated with Con A (10 ,ug/ml) at 37°C in a humidified 5% CO2 incubator. After 48 h, cell-free supernates were stored at -70°C until used. (Fig. 4) . Cells incubated with dimethyl sulfoxide (7 mM; Fisher Scientific Co.), the solvent used to dissolve cytochalasin B, were not inhibited from polarizing. Preincubation of the cells (30 min, 22°C) with 10 mM sodium azide also prevented polarization (Fig. 4) .
RESULTS

Polarization of human
Evidence that polarized cells are monocytes. To test if the specificity of chemoattractants for inducing monocyte polarization paralleled their ability to induce chemotaxis, cells were incubated for 20 min at 37°C with varying concentrations of FMLP, FMMM, FNILP, or FMP. The results (Fig. 5) demonstrate that FMMM, FNILP, or FMP are all capable of inducing monocytes to polarize in suspension but they are substantially less potent than FMLP. The potency of these peptides for inducing polarization closely parallels their potency for inducing chemotaxis with a correlation coefficient of r > 0.99 (Fig. 6) . The unformylated peptide MMM, which is not chemotactic, did not induce polarization.
Ability of other chemoattractants and other membrane-binding agents to induce polarization. To see if other chemotactic factors could cause monocytes to polarize, AHS and LDCF were used. Cells were incubated with varying concentrations of AHS or LDCF, fixed, and the percentage of monocytes polarized was calculated (Fig. 7) . As little as 0.01% AHS induced polarization, whereas the peak response was obtained at -5%. Significant polarization was also induced by as little as 5.0% LDCF with the maximum response occurring at 10%.
The effects on polarization of other membranebinding but nonchemotactic agents such as phorbol 12-myristate 13-acetate, Con A, or PHA were also tested. The results (Table II) (Table III) . When concentrations of chemoattractants that induced less than the maximal response were combined, the percentage of polarized cells increased but did not exceed the maximum.
Evidence for cross-desensitization of monocyte polarization by FMLP. High concentrations (0.1-10 ,uM) of FMLP desensitized the monocytes' ability to polarize (Fig. 2) . This effect was time dependent in that after 1 (Table IV) DISCUSSION The migration of leukocytes to gradients of chemoattractants in vitro is initiated by the cells' assuming a polarized oriented position towards the direction of movement. Polarized cells can be identified by their triangular shape characterized by a flattened lamellapod at the leading edge and pointed uropod at the tail (19) .
Our data demonstrate that human blood monocytes in suspension assume a polarized configuration when ex- The existence of subpopulations of monocytes with differing responsiveness to chemotactic factors is difficult to verify using unfractionated mononuclear leukocytes and currently available chemotaxis assays. The develqpment of the polarization assay allowed us to directly examine one early response of the monocytes to chemotactic factors. Our results indicate that, on the average, a maximum of -60% of blood monocytes are able to assume a polarized configuration in the presence of a chemotactic stimulus. Because some of these cells may be polarized nonspecifically, i.e. to factors present in the media, etc., the maximum number of human monocytes that polarize to chemotactic stimuli is probably about 50%. Thus the fact that only up to 40% of the monocytes put on top of a chemotaxis filter migrate through the filter is not surprising since not all cells capable of sensing chemoattractants and polarizing would necessarily be capable of migrating as well.
The data further indicate that the subpopulation of human monocytes that responds by polarization to a chemotactic stimulus is capable of responding to several different chemotactic stimuli. Support for this contention comes from our results, which show that a population of cells maximally polarized by one stimulus cannot respond further to another stimulus; however, a population of cells that have less than maximally responded to one stimulus can indeed be further polarized to the maximal value by a second stimulus. The finding that combinations of less than maximal concentrations does not result in strictly additive increases in polarization is consistent with the concept that the responsive cells share receptors for the different chemotactic stimuli. The results that show that polarization of monocytes to five different chemotactic factors can be blocked by a desensitizing concentration of one of those factors further supports the concept of a common, responsive, monocyte subpopulation.
Why only a subpopulation of monocytes polarizes to chemotactic factors has not yet been determined. The defect in the nonresponsive cells may be related to deficiencies in the binding of chemotactic factors to the cells or to defects in the subsequent transmembrane events that follow binding and are required to initiate polarization and migration. It is also not known whether the ability of monocytes to polarize to chemotactic stimuli is related to the level of cellular differen-tiation or whether distinct monocyte cell lines exist. These possibilities should provide fruitful areas for investigation.
In any case the data indicate that human blood monocytes in suspension assumne polarized configurations in response to various chemotactic stimuli. This response appears to be characteristic of a distinct subpopulation of these cells. The assay for this activity is rapid and quantitative and may thus be extremely useful for studies evaluating the function of monocytes in individuals with neoplasia, immune deficiency, or inflammatory disorders.
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